The Named Patient Support pathway enables physicians to access unapproved medicines for individual patients with serious or life-threatening conditions when no suitable approved treatments are available. In some of the cases its on a compassionate basis.
We at Arkon solutions are committed to provide you with a comprehensive support system designed to empower patients throughout their treatment journey and beyond. Accessing critical care medicines can sometimes create unforeseen challenges due to multifactorial determinants impacting their availability and regulatory status of medicines including restrictions in scope of distribution network continuity, local regulatory registration limitations and transitional phases of life-cycle. This encompasses novel treatment entities pending requisite authorization as well as previously authorized formulations subjected to regulatory withdrawal, discontinuation or market suspension in your home country of a patient. Navigating these complexities is precisely where we can assist and provide potential avenues for access. We make sure to support the patients with right guidance and right resources at every stage which makes them feel confident and assured.